In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Heart Failure

Open-access research on all aspects of heart failure and its comorbidities: advancing knowledge about heart failure worldwide

 

ESC Heart Failure is the open access journal of the Heart Failure Association.

The journal improves the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure.

Submit your paper

Fast Facts

  • Editor-in-Chief: Professor Piotr Ponikowski (PL)
  • Current volume: 10 (year 2024)
  • Issues per volume: 6
  • Impact Factor 2023 : 3.2

Editor-in-Chief History

Name Start Date End Date
Professor Stefan D. Anker 01/01/2014 31/08/2022
Professor Magnus Bäck (Interim Editor-in-Chief) 01/09/2022 31/03/2024
Professor Piotr Ponikowski  01/04/2024  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.

Most recent articles from ESC HF

19 Nov 2024
Machine learning‐based prediction of elevated N terminal pro brain natriuretic peptide among US general population
Author(s): Yuichiro Mori, Shingo Fukuma, Kyohei Yamaji, Atsushi Mizuno, Naoki Kondo, Kosuke Inoue
16 Nov 2024
Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York
Author(s): Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao
18 Nov 2024
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
Author(s): Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer
16 Nov 2024
An unexpected ally in heart failure treatment: Unlocking the potential of sodium‐glucose cotransporter 2 inhibitors across patient subpopulations
Author(s): Sander Trenson, Mateusz Sokolski